Breaking News Instant updates and real-time market news.

2019-12-02 07:34:26 AQST Aquestive Therapeutics $7.80 0.53 (7.29%) 07:34 12/02/19 12/02 07:34 12/02/19 07:34	Aquestive Therapeutics completes rolling submission of Libervant NDA Aquestive Therapeutics announced the completion, as planned, of the rolling submission of a New Drug Application to the U.S. Food and Drug Administration for its therapeutic candidate Libervant Buccal Film for the management of seizure clusters. Libervant has received orphan drug designation from the FDA.
AQST Aquestive Therapeutics $7.80 0.53 (7.29%) 04/22/19 04/22/19 INITIATION Fly Intel: Top five analyst initiations Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Zoom Video (ZM) initiated with a Sell at Summit Insights. 2. Agenus (AGEN) initiated with a Buy at B. Riley FBR. 3. Aquestive Therapeutics (AQST) initiated with a Buy at H.C. Wainwright. 4. Akamai (AKAM) initiated with a Buy at Needham. 5. Six Flags (SIX) initiated with a Hold at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here. 06/10/19 HCWC 06/10/19 NO CHANGE Target $10 HCWC Buy Aquestive Therapeutics recent selloff unwarranted, says H.C. Wainwright H.C. Wainwright analyst Raghuram Selvaraju believes the recent downward pressure on the stock has been unwarranted, particularly given the "faster-than-previously projected" progress of the Libervant PK study. The analyst reiterates a Buy rating on the shares with a $10 price target. 07/16/19 HCWC 07/16/19 NO CHANGE Target $12 HCWC Buy Aquestive Therapeutics price target raised to $12 from $10 at H.C. Wainwright H.C. Wainwright analyst Raghuram Selvaraju raised his price target for Aquestive Therapeutics to $12 from $10 saying the company's financial burden is reduced following the completion of its $70M private placement. The refinancing "substantially reduces" Aquestive's quarterly interest payment burden and provides further financial flexibility during the period that may elapse before the company can achieve sustainable profitability, Selvaraju tells investors in a research note. He keeps a Buy rating on the shares. 12/02/19 HCWC 12/02/19 NO CHANGE Target $14 HCWC Buy Aquestive Therapeutics price target raised to $14 from $12 at H.C. Wainwright H.C. Wainwright analyst Raghuram Selvaraju raised his price target for Aquestive Therapeutics to $14 from $12 and reiterates a Buy rating on the shares. Earlier this month, Aquestive's licensee Sunovion announced the resubmission of its New Drug Application to the FDA for apomorphine sublingual film to treat motor fluctuations experienced by people living with Parkinson's disease in response to the Complete Response Letter received in late January 2019, Selvaraju tells investors in a research note. The resubmitted application included information about intended packaging as well as additional analyses of clinical data, which is an indication of Sunovion's continued commitment to the product and ought to pave the way for potential approval of the drug next year, says the analyst.

2019-12-02 07:34:26

AQST

Aquestive Therapeutics

$7.80: 0.53 (7.29%)

07:34

12/02/19

12/02

07:34

12/02/19

07:34

Aquestive Therapeutics completes rolling submission of Libervant NDA

Aquestive Therapeutics announced the completion, as planned, of the rolling submission of a New Drug Application to the U.S. Food and Drug Administration for its therapeutic candidate Libervant Buccal Film for the management of seizure clusters. Libervant has received orphan drug designation from the FDA.

AQST Aquestive Therapeutics

$7.80: 0.53 (7.29%)

04/22/19

06/10/19: HCWC

07/16/19: HCWC

12/02/19: HCWC

TODAY'S FREE FLY STORIES

EADSY Airbus $0.00 (0.00%) 06:08 12/13/19 12/13 06:08 12/13/19 06:08 Hot Stocks	Airbus acquires industrial automation company MTM Robotics » Airbus has acquired… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
COP ConocoPhillips $62.58 0.87 (1.41%) 06:06 12/13/19 12/13 06:06 12/13/19 06:06 Initiation	ConocoPhillips initiated » ConocoPhillips initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	04 Feb 23 Mar
OGI Organigram $2.57 (0.00%) 06:06 12/13/19 12/13 06:06 12/13/19 06:06 Hot Stocks	Organigram gets Health Canada's approval for 16 additional cultivation rooms » Organigram is pleased to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	13 Dec
OIS Oil States $17.64 0.55 (3.22%) 06:06 12/13/19 12/13 06:06 12/13/19 06:06 Downgrade	Oil States rating change » Oil States downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	23 Mar
SSNLF Samsung $0.00 (0.00%) 06:06 12/13/19 12/13 06:06 12/13/19 06:06 Periodicals	Samsung VP receives jail term for union-busting activities, Reuters reports » Samsung Electronics VP… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

HBI Hanesbrands $15.18 0.19 (1.27%) 06:04 12/13/19 12/13 06:04 12/13/19 06:04 Downgrade	Hanesbrands rating change » Hanesbrands downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
RGS Regis $17.31 0.15 (0.87%) 06:03 12/13/19 12/13 06:03 12/13/19 06:03 Hot Stocks	Regis enters franchise arrangement with Bushell Investment Group » Regis announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
PTEN Patterson-UTI $10.38 0.29 (2.87%) 06:03 12/13/19 12/13 06:03 12/13/19 06:03 Downgrade	Patterson-UTI rating change » Patterson-UTI downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Feb
PTEN Patterson-UTI $10.38 0.29 (2.87%) 06:03 12/13/19 12/13 06:03 12/13/19 06:03 Downgrade	Patterson-UTI rating change » Patterson-UTI downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Feb
MOH Molina Healthcare $129.62 1.725 (1.35%) 06:00 12/13/19 12/13 06:00 12/13/19 06:00 Hot Stocks	Molina Healthcare announces $500M share repurchase program » Molina Healthcare… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

HBAN Huntington Bancshares $15.59 0.39 (2.57%) 05:58 12/13/19 12/13 05:58 12/13/19 05:58 Downgrade	Huntington Bancshares rating change » Huntington Bancshares… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AAPL Apple $271.45 0.74 (0.27%) 05:58 12/13/19 12/13 05:58 12/13/19 05:58 Periodicals	Apple acquires U.K.-based Spectral Edge, Bloomberg reports » Apple has acquired… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
UUGRY United Utilities $0.00 (0.00%) 05:55 12/13/19 12/13 05:55 12/13/19 05:55 Upgrade	United Utilities rating change » United Utilities upgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
HINOY Hino Motors $0.00 (0.00%) 05:54 12/13/19 12/13 05:54 12/13/19 05:54 Downgrade	Hino Motors rating change » Hino Motors downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
DAO Youdao $14.18 -0.17 (-1.18%) 05:54 12/13/19 12/13 05:54 12/13/19 05:54 Initiation	Youdao initiated » Youdao initiated with an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

ASAZY Assa Abloy $0.00 (0.00%) 05:53 12/13/19 12/13 05:53 12/13/19 05:53 Upgrade	Assa Abloy rating change » Assa Abloy upgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ATDRY Auto Trader Group $0.00 (0.00%) 05:53 12/13/19 12/13 05:53 12/13/19 05:53 Upgrade	Auto Trader Group rating change » Auto Trader Group… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
BDNNY Boliden $0.00 (0.00%) 05:51 12/13/19 12/13 05:51 12/13/19 05:51 Downgrade	Boliden rating change » Boliden downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
VRTX Vertex $220.43 0.37 (0.17%) , REGN Regeneron $372.10 -1.41 (-0.38%) 05:39 12/13/19 12/13 05:39 12/13/19 05:39 Recommendations	Vertex, Regeneron analyst commentary » Credit Suisse replaces… VRTX Vertex $220.43 0.37 (0.17%) REGN Regeneron $372.10 -1.41 (-0.38%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Mar
OPI Office Properties $32.93 -1.02 (-3.00%) 05:36 12/13/19 12/13 05:36 12/13/19 05:36 Downgrade	Office Properties rating change » Office Properties… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

VOLVY Volvo $0.00 (0.00%) 05:36 12/13/19 12/13 05:36 12/13/19 05:36 Hot Stocks	Volvo appoints Scott Rafkin as Chief Digital Officer » Scott Rafkin, currently… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AMGN Amgen $236.18 2.22 (0.95%) 05:36 12/13/19 12/13 05:36 12/13/19 05:36 Recommendations	Amgen analyst commentary » Amgen price target raised… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
NDSN Nordson $162.94 -4.5 (-2.69%) 05:36 12/13/19 12/13 05:36 12/13/19 05:36 Upgrade	Nordson rating change » Nordson upgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
NBIX Neurocrine $111.41 -1.85 (-1.63%) 05:35 12/13/19 12/13 05:35 12/13/19 05:35 Downgrade	Neurocrine rating change » Neurocrine downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
NDSN Nordson $162.94 -4.5 (-2.69%) 05:35 12/13/19 12/13 05:35 12/13/19 05:35 Downgrade	Nordson rating change » Nordson downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

HZNP
Today at 08:00

Dermatologic & Ophthalmic Drugs Advisory Committee Meeting Government Event

FDA White Oak Campus--10903 New Hampshire Ave--Bldg 31 Conference Center--Great Room 1503, Silver Spring, MD
Today at 08:00

Economics & Strategy--UK Industry Meetings
Today at 08:30

Import Prices M/M: November 2019 Government Event
Today at 08:30

Import Prices Y/Y: November 2019 Government Event
Today at 08:30

Retail Sales M/M: November 2019 Government Event
Today at 08:30

Export Prices M/M: November 2019 Government Event
Today at 08:30

Retail Sales less Autos M/M: November 2019 Government Event
Today at 08:30

Export Prices Y/Y: November 2019 Government Event
Today at 08:30

Retail Sales less Autos & Gas M/M: November 2019 Government Event
Today at 08:30

Retail Sales Control Group M/M: November 2019 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CRWD X CRWD Crowdstrike Block Trade Managers: Goldman Sachs Priced at: $49.40 2.2M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AUPH X AUPH Aurinia Pharmaceuticals Secondary Managers: Jefferies & SVB Leerink, H.C. Wainwright, Oppenheimer, Bloom Burton Priced at: $15.00 11.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XAIR X XAIR Beyond Air Secondary Managers: SunTrust, National Securities, Roth Capital, Laidlaw Priced at: $3.66 2.325M Shares ABR X ABR Arbor Realty Spot Secondary Managers: JPMorgan, JMP Securities & Raymond James Priced at: $14.14 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CFRX X CFRX ContraFect Spot Secondary Managers: Maxim Priced at: $.27 37.15M Shares RHP X RHP Ryman Hospitality Spot Secondary Managers: BofA/Merrill, JPMorgan & Wells Fargo Priced at: $85.60 3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SCYX X SCYX Scynexis Spot Secondary Managers: H.C. Wainwright Priced at: $.90 38.89M Shares
Tues	XP X XP XP IPO Managers: Goldman Sachs, JPMorgan, Morgan Stanley, XP & Itau BBA, BofA/Merrill, Citi, Credit Suisse, UBS Priced at: $27.00 72.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CNST X CNST Constellation Pharmaceuticals Spot Secondary Managers: JPMorgan, Jefferies & Cowen, RBC Capital, SunTrust Priced at: $34.50 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GMRE X GMRE Global Medical REIT Spot Secondary Managers: Stifel, BMO Capital, Baird, KeyBanc & SunTrust Priced at: $13.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Jaffray & Stifel, BTIG, JMP Securities, SunTrust Priced at: $36.50 1.57M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDGL X MDGL Madrigal Pharmaceuticals Spot Secondary Managers: Goldman Sachs Priced at: $107.85 1.2M Shares MRNS X MRNS Marinus Pharmaceuticals Spot Secondary Managers: Oppenheimer & Ladenburg Priced at: $1.25 28M Shares PACK X PACK Ranpak Holdings Spot Secondary Managers: Craig-Hallum Priced at: $6.50 15.384M Shares PMT X PMT PennyMac Mortgage Spot Secondary Managers: Morgan Stanley, Credit Suisse, BofA/Merrill, JPMorgan & Barclays, Nomura Instinet, Piper Jaffray Priced at: $22.10 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCKT X RCKT Rocket Pharmaceuticals Spot Secondary Managers: JPMorgan, Cowen & Evercore ISI, LifeSci Priced at: $22.25 3.82M Shares
Wed	BILL X BILL Bill.com IPO Managers: Goldman Sachs, BofA/Merrill, Jefferies & KeyBanc, Canaccord, Needham, William Blair Priced at: $22.00 9.824M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EH X EH Ehang IPO Managers: Morgan Stanley, Needham, Tigress Financial, Prime Number Priced at: $12.50 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LVGO X LVGO Livongo Health Secondary Managers: Morgan Stanley, Goldman Sachs & JPMorgan Priced at: $27.00 2.78M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MNRL X MNRL Brigham Minerals Secondary Managers: Credit Suisse, Goldman Sachs & RBC Capital Priced at: $18.10 11M Shares MNTA X MNTA Momenta Secondary Managers: Goldman Sachs & JPMorgan, Stifel Priced at: $15.50 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AKTS X AKTS Akoustis Spot Secondary Managers: Craig-Hallum, Roth Capital, Loop Capital Priced at: $6.25 4.8M Shares ASMB X ASMB Assembly Biosciences Spot Secondary Managers: Jefferies & SVB Leerink Priced at: $16.50 5.152M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FTSV X FTSV Forty Seven Spot Secondary Managers: Morgan Stanley & Credit Suisse Priced at: $35.00 4.86M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	HCCO X HCCO Healthcare Merger Corp. IPO Managers: Cantor Fitzgerald Priced at: $10.00 22M Shares SPT X SPT Sprout Social IPO Managers: Goldman Sachs, Morgan Stanley, KeyBanc & William Blair, Canaccord, Stifel Priced at: $17.00 8.824M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AQST X AQST Aquestive Therapeutics Secondary Managers: BMO Capital Priced at: $5.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PHR X PHR Phreesia Secondary Managers: JPMorgan, Wells Fargo, William Blair, Allen & Co., Piper Jaffray, Baird, Raymond James Priced at: $26.00 6.75M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	LULU X LULU Lululemon Block Trade Managers: Morgan Stanley $218.50-220.00 2.6M Shares OCFT X OCFT OneConnect IPO Managers: Morgan Stanley, Goldman Sachs, JPMorgan & Ping An of China, BofA/Merrill, HSBC, CLSA, KeyBanc $9.00-10.00 26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASPU X ASPU Aspen Group Spot Secondary Managers: Canaccord $7.55 Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Aquestive Therapeutics completes rolling submission of Libervant NDA

TODAY'S FREE FLY STORIES

Get Full Fly Access